BRR : 9082807
Tender Brief : 21-22 / 316 Pvms No 011772 Inj Human Insulin Analougue Aspart Premix 30 Percent Insulin / 70 Percent Insulin Protamine Aspart Suspension 100 Iu / Ml ( Monocomponent Insulin, Recombinant Dna Origin ) 3 Ml Pfs Pfp , Pvms No 011772 Inj Human Insulin Analougue Aspart Premix 30% Insulin / 70% Insulin Protamine Aspart Suspension 100 Iu / Ml ( Monocomponent Insulin, Recombinant Dna Origin ) 3 Ml Pfs / Pfp Read More
Tender Value
₹
Ref. Document
Submission Date
11-01-2022
Participated Bidder List
1 No of Bidder(s)
| Sr No. | Bidder Name | Bid Analytics | Technical Bid | Financial Bid | AOC | Bid Value | Rank |
|---|---|---|---|---|---|---|---|
| 1 | cnet-technologies | Bid Analytics |
Work Detail
21-22 / 316 pvms no 011772 inj human insulin analougue aspart premix 30 percent insulin / 70 percent insulin protamine aspart suspension 100 iu / ml ( monocomponent insulin, recombinant dna origin ) 3 ml pfs pfp , pvms no 011772 inj human insulin analougue aspart premix 30% insulin / 70% insulin protamine aspart suspension 100 iu / ml ( monocomponent insulin, recombinant dna origin ) 3 ml pfs / pfp
View Original Notice/Document
Result Documents
Tender Documents
Disclaimer
We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender
Technical Evaluation In Progress
Technical bid evaluation is currently in progress. Awarded bidder details will be available after completion of technical scrutiny.
TechnicalBid
Similar Tenders Results